Abdulkareem Musa, Petersen Steffen E
Barts Heart Centre, Barts Health National Health Service (NHS) Trust, London, United Kingdom.
National Institute for Health Research (NIHR) Barts Biomedical Research Centre, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Front Artif Intell. 2021 May 14;4:652669. doi: 10.3389/frai.2021.652669. eCollection 2021.
COVID-19 has created enormous suffering, affecting lives, and causing deaths. The ease with which this type of coronavirus can spread has exposed weaknesses of many healthcare systems around the world. Since its emergence, many governments, research communities, commercial enterprises, and other institutions and stakeholders around the world have been fighting in various ways to curb the spread of the disease. Science and technology have helped in the implementation of policies of many governments that are directed toward mitigating the impacts of the pandemic and in diagnosing and providing care for the disease. Recent technological tools, artificial intelligence (AI) tools in particular, have also been explored to track the spread of the coronavirus, identify patients with high mortality risk and diagnose patients for the disease. In this paper, areas where AI techniques are being used in the detection, diagnosis and epidemiological predictions, forecasting and social control for combating COVID-19 are discussed, highlighting areas of successful applications and underscoring issues that need to be addressed to achieve significant progress in battling COVID-19 and future pandemics. Several AI systems have been developed for diagnosing COVID-19 using medical imaging modalities such as chest CT and X-ray images. These AI systems mainly differ in their choices of the algorithms for image segmentation, classification and disease diagnosis. Other AI-based systems have focused on predicting mortality rate, long-term patient hospitalization and patient outcomes for COVID-19. AI has huge potential in the battle against the COVID-19 pandemic but successful practical deployments of these AI-based tools have so far been limited due to challenges such as limited data accessibility, the need for external evaluation of AI models, the lack of awareness of AI experts of the regulatory landscape governing the deployment of AI tools in healthcare, the need for clinicians and other experts to work with AI experts in a multidisciplinary context and the need to address public concerns over data collection, privacy, and protection. Having a dedicated team with expertise in medical data collection, privacy, access and sharing, using federated learning whereby AI scientists hand over training algorithms to the healthcare institutions to train models locally, and taking full advantage of biomedical data stored in biobanks can alleviate some of problems posed by these challenges. Addressing these challenges will ultimately accelerate the translation of AI research into practical and useful solutions for combating pandemics.
新冠疫情造成了巨大痛苦,影响了人们的生活并导致死亡。这种冠状病毒易于传播,暴露了全球许多医疗体系的薄弱之处。自疫情出现以来,世界各国政府、研究团体、商业企业以及其他机构和利益相关者一直在以各种方式努力遏制疾病的传播。科学技术有助于许多国家政府实施旨在减轻疫情影响的政策,并有助于疾病的诊断和治疗。最近还探索了一些技术工具,尤其是人工智能(AI)工具,以追踪冠状病毒的传播、识别高死亡风险患者并诊断疾病。本文讨论了人工智能技术在新冠疫情检测、诊断、流行病学预测、预报及社会管控方面的应用领域,重点介绍了成功应用的领域,并强调了在抗击新冠疫情及未来大流行方面取得重大进展需要解决的问题。已经开发了几种使用胸部CT和X光图像等医学成像方式诊断新冠的人工智能系统。这些人工智能系统在图像分割、分类和疾病诊断算法的选择上主要有所不同。其他基于人工智能的系统则专注于预测新冠的死亡率、患者长期住院情况和患者预后。人工智能在抗击新冠疫情方面具有巨大潜力,但由于数据获取受限、人工智能模型需要外部评估、人工智能专家对医疗保健领域人工智能工具部署的监管环境缺乏认识、临床医生和其他专家需要在多学科背景下与人工智能专家合作以及需要解决公众对数据收集、隐私和保护的担忧等挑战,这些基于人工智能的工具目前成功的实际应用仍然有限。组建一个在医学数据收集、隐私、获取和共享方面具有专业知识的专门团队,采用联邦学习,即人工智能科学家将训练算法交给医疗机构在本地训练模型,并充分利用生物样本库中存储的生物医学数据,可以缓解这些挑战带来的一些问题。应对这些挑战最终将加速人工智能研究转化为抗击大流行的实用解决方案。